Adalimumab-ryvk(This product is SIMLANDI (adalimumab-ryvk). SIMLANDI (adalimumab-ryvk) is biosimilar to HUMIRA (adalimumab).)

Teva Pharmaceuticals USA, Inc.🇺🇸 United States

FDA Page

Effective Date: Dec 31, 2025
Approval ID: 2d19a877-1f5a-4731-800a-dddadc424080
Products: 5 registered
Version: 1

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

This product is SIMLANDI (adalimumab-ryvk). SIMLANDI (adalimumab-ryvk) is biosimilar to HUMIRA (adalimumab).

Quick Stats

Total Products5

Labelers2

Label Sections51

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.